Vaxcyte Free Cash Flow vs Other Non Cash Items Analysis

PCVX Stock

USD 88.32 3.12 3.41%

Vaxcyte financial indicator trend analysis is much more than just breaking down Vaxcyte prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxcyte is a good investment. Please check the relationship between Vaxcyte Free Cash Flow and its Other Non Cash Items accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Free Cash Flow vs Other Non Cash Items

Free Cash Flow vs Other Non Cash Items Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxcyte Free Cash Flow account and Other Non Cash Items. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Vaxcyte's Free Cash Flow and Other Non Cash Items is 0.86. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Vaxcyte, assuming nothing else is changed. The correlation between historical values of Vaxcyte's Free Cash Flow and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Vaxcyte are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Free Cash Flow i.e., Vaxcyte's Free Cash Flow and Other Non Cash Items go up and down completely randomly.

Correlation Coefficient

0.86

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Other Non Cash Items

Most indicators from Vaxcyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxcyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.At this time, Vaxcyte's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 768 M in 2025, whereas Enterprise Value Over EBITDA is likely to drop (11.65) in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	9.2M	3.2M	3.6M	4.0M
Net Interest Income	8.4M	62.9M	72.3M	76.0M

Depreciation And Amortization Net Interest Income

Vaxcyte fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Long Term Debt Total	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity
Total Assets		0.95	0.97	1.0	-0.94	0.98	-0.98	0.59	0.74	0.07	-0.74	1.0	0.87	-0.74	0.87	0.63	1.0	0.97	0.88	0.97	0.96	-0.69	-0.7	0.95	0.94	0.77
Other Current Liab	0.95		0.99	0.93	-0.81	0.88	-0.93	0.52	0.51	-0.19	-0.63	0.92	0.83	-0.63	0.76	0.68	0.92	0.89	0.78	0.93	0.99	-0.57	-0.46	0.99	1.0	0.63
Total Current Liabilities	0.97	0.99		0.96	-0.86	0.92	-0.95	0.6	0.57	-0.12	-0.69	0.95	0.85	-0.69	0.82	0.67	0.95	0.93	0.81	0.96	0.98	-0.64	-0.53	0.98	0.98	0.7
Total Stockholder Equity	1.0	0.93	0.96		-0.95	0.99	-0.97	0.59	0.75	0.1	-0.71	0.99	0.86	-0.71	0.88	0.57	1.0	0.98	0.88	0.97	0.95	-0.67	-0.72	0.94	0.93	0.78
Other Liab	-0.94	-0.81	-0.86	-0.95		-0.98	0.94	-0.65	-0.83	-0.34	0.76	-0.95	-0.84	0.76	-0.95	-0.49	-0.95	-0.98	-0.93	-0.95	-0.86	0.73	0.8	-0.83	-0.8	-0.9
Net Tangible Assets	0.98	0.88	0.92	0.99	-0.98		-0.96	0.63	0.82	0.21	-0.76	0.99	0.86	-0.76	0.92	0.55	0.99	0.99	0.9	0.96	0.9	-0.72	-0.8	0.89	0.87	0.83
Retained Earnings	-0.98	-0.93	-0.95	-0.97	0.94	-0.96		-0.59	-0.72	-0.11	0.77	-0.97	-0.92	0.77	-0.88	-0.68	-0.98	-0.97	-0.9	-0.96	-0.95	0.74	0.67	-0.94	-0.93	-0.81
Accounts Payable	0.59	0.52	0.6	0.59	-0.65	0.63	-0.59		0.66	0.06	-0.73	0.62	0.67	-0.73	0.77	0.42	0.62	0.69	0.43	0.69	0.47	-0.72	-0.62	0.46	0.46	0.8
Cash	0.74	0.51	0.57	0.75	-0.83	0.82	-0.72	0.66		0.45	-0.7	0.79	0.72	-0.7	0.77	0.41	0.79	0.77	0.65	0.68	0.52	-0.69	-0.99	0.5	0.48	0.8
Other Assets	0.07	-0.19	-0.12	0.1	-0.34	0.21	-0.11	0.06	0.45		-0.39	0.12	0.13	-0.39	0.38	-0.1	0.12	0.22	0.45	0.11	-0.06	-0.42	-0.45	-0.12	-0.18	0.46
Long Term Debt	-0.74	-0.63	-0.69	-0.71	0.76	-0.76	0.77	-0.73	-0.7	-0.39		-0.75	-0.82	1.0	-0.88	-0.67	-0.75	-0.82	-0.77	-0.76	-0.65	1.0	0.65	-0.62	-0.59	-0.86
Cash And Short Term Investments	1.0	0.92	0.95	0.99	-0.95	0.99	-0.97	0.62	0.79	0.12	-0.75		0.87	-0.75	0.89	0.62	1.0	0.98	0.88	0.96	0.93	-0.71	-0.76	0.92	0.91	0.79
Common Stock Shares Outstanding	0.87	0.83	0.85	0.86	-0.84	0.86	-0.92	0.67	0.72	0.13	-0.82	0.87		-0.82	0.83	0.77	0.87	0.88	0.8	0.86	0.84	-0.8	-0.62	0.82	0.81	0.86
Long Term Debt Total	-0.74	-0.63	-0.69	-0.71	0.76	-0.76	0.77	-0.73	-0.7	-0.39	1.0	-0.75	-0.82		-0.88	-0.67	-0.75	-0.82	-0.77	-0.76	-0.65	1.0	0.65	-0.62	-0.59	-0.86
Capital Surpluse	0.87	0.76	0.82	0.88	-0.95	0.92	-0.88	0.77	0.77	0.38	-0.88	0.89	0.83	-0.88		0.49	0.89	0.96	0.9	0.94	0.79	-0.85	-0.73	0.77	0.73	0.95
Total Liab	0.63	0.68	0.67	0.57	-0.49	0.55	-0.68	0.42	0.41	-0.1	-0.67	0.62	0.77	-0.67	0.49		0.62	0.58	0.51	0.57	0.65	-0.65	-0.31	0.65	0.66	0.49
Total Current Assets	1.0	0.92	0.95	1.0	-0.95	0.99	-0.98	0.62	0.79	0.12	-0.75	1.0	0.87	-0.75	0.89	0.62		0.98	0.88	0.96	0.93	-0.71	-0.76	0.92	0.91	0.79
Common Stock	0.97	0.89	0.93	0.98	-0.98	0.99	-0.97	0.69	0.77	0.22	-0.82	0.98	0.88	-0.82	0.96	0.58	0.98		0.92	0.99	0.92	-0.79	-0.73	0.9	0.88	0.88
Property Plant Equipment	0.88	0.78	0.81	0.88	-0.93	0.9	-0.9	0.43	0.65	0.45	-0.77	0.88	0.8	-0.77	0.9	0.51	0.88	0.92		0.89	0.86	-0.74	-0.61	0.83	0.79	0.83
Short Long Term Debt Total	0.97	0.93	0.96	0.97	-0.95	0.96	-0.96	0.69	0.68	0.11	-0.76	0.96	0.86	-0.76	0.94	0.57	0.96	0.99	0.89		0.95	-0.72	-0.64	0.93	0.92	0.84
Property Plant And Equipment Net	0.96	0.99	0.98	0.95	-0.86	0.9	-0.95	0.47	0.52	-0.06	-0.65	0.93	0.84	-0.65	0.79	0.65	0.93	0.92	0.86	0.95		-0.6	-0.47	1.0	0.99	0.67
Current Deferred Revenue	-0.69	-0.57	-0.64	-0.67	0.73	-0.72	0.74	-0.72	-0.69	-0.42	1.0	-0.71	-0.8	1.0	-0.85	-0.65	-0.71	-0.79	-0.74	-0.72	-0.6		0.65	-0.57	-0.53	-0.85
Net Debt	-0.7	-0.46	-0.53	-0.72	0.8	-0.8	0.67	-0.62	-0.99	-0.45	0.65	-0.76	-0.62	0.65	-0.73	-0.31	-0.76	-0.73	-0.61	-0.64	-0.47	0.65		-0.45	-0.43	-0.73
Non Current Assets Total	0.95	0.99	0.98	0.94	-0.83	0.89	-0.94	0.46	0.5	-0.12	-0.62	0.92	0.82	-0.62	0.77	0.65	0.92	0.9	0.83	0.93	1.0	-0.57	-0.45		1.0	0.64
Non Currrent Assets Other	0.94	1.0	0.98	0.93	-0.8	0.87	-0.93	0.46	0.48	-0.18	-0.59	0.91	0.81	-0.59	0.73	0.66	0.91	0.88	0.79	0.92	0.99	-0.53	-0.43	1.0		0.6
Common Stock Total Equity	0.77	0.63	0.7	0.78	-0.9	0.83	-0.81	0.8	0.8	0.46	-0.86	0.79	0.86	-0.86	0.95	0.49	0.79	0.88	0.83	0.84	0.67	-0.85	-0.73	0.64	0.6

Click cells to compare fundamentals

Vaxcyte Account Relationship Matchups

Vaxcyte fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	392.8M	324.3M	1.0B	1.4B	1.6B	1.7B
Other Current Liab	17.1M	11.4M	18.9M	123.6M	142.2M	149.3M
Total Current Liabilities	46.9M	28.7M	40.5M	145.3M	167.1M	175.5M
Total Stockholder Equity	345.8M	284.0M	953.6M	1.2B	1.4B	1.5B
Other Liab	259K	122K	96K	9K	8.1K	7.7K
Net Tangible Assets	(106.4M)	345.8M	284.0M	953.6M	1.1B	1.2B
Retained Earnings	(198.6M)	(298.6M)	(522.1M)	(924.4M)	(832.0M)	(790.4M)
Accounts Payable	29.8M	6.8M	9.8M	14.6M	16.8M	10.8M
Cash	386.2M	69.0M	834.7M	397.5M	457.1M	290.5M
Other Assets	550K	5.0M	5.4M	1.0	1.15	1.09
Cash And Short Term Investments	386.2M	246.0M	931.4M	1.1B	1.2B	1.3B
Common Stock Shares Outstanding	51.1M	51.9M	64.9M	97.2M	111.7M	57.4M
Capital Surpluse	1.3M	3.0M	544.4M	582.8M	670.3M	703.8M
Total Liab	47.0M	40.3M	52.6M	167.4M	192.6M	96.9M
Total Current Assets	389.0M	256.3M	942.6M	1.1B	1.3B	1.3B
Common Stock	54K	56K	82K	98K	112.7K	118.3K
Property Plant Equipment	3.4M	3.3M	35.9M	31.6M	36.4M	38.2M
Property Plant And Equipment Net	3.3M	35.9M	31.6M	110.6M	127.2M	133.6M
Net Debt	(386.2M)	(52.2M)	(816.7M)	(368.2M)	(331.4M)	(348.0M)
Non Current Assets Total	3.8M	68.0M	63.6M	312.0M	358.8M	376.7M
Non Currrent Assets Other	550K	5.0M	5.4M	38.7M	44.5M	46.7M
Liabilities And Stockholders Equity	392.8M	324.3M	1.0B	1.4B	1.6B	1.7B
Non Current Liabilities Total	122K	11.6M	12.0M	22.1M	19.9M	18.9M
Capital Lease Obligations	0.0	16.8M	17.9M	29.2M	33.6M	35.3M
Other Current Assets	2.5M	9.2M	5.3M	15.7M	18.1M	19.0M
Other Stockholder Equity	151.5M	582.8M	1.5B	2.2B	2.5B	2.6B
Net Invested Capital	345.8M	284.0M	953.6M	1.2B	1.4B	1.5B
Accumulated Other Comprehensive Income	(392.8M)	(241K)	(361K)	179K	205.9K	216.1K
Capital Stock	54K	56K	82K	98K	112.7K	118.3K
Non Current Liabilities Other	242K	112K	96K	9K	8.1K	7.7K
Net Working Capital	342.1M	227.6M	902.0M	950.6M	1.1B	1.1B
Net Receivables	300K	1.2M	1M	3.6M	4.1M	4.4M
Inventory	(300K)	(1.2M)	(1M)	(6.2M)	(5.5M)	(5.3M)
Property Plant And Equipment Gross	3.3M	39.5M	37.8M	154.6M	177.8M	186.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaxcyte Free Cash Flow vs Other Non Cash Items Analysis

Free Cash Flow vs Other Non Cash Items

Free Cash Flow vs Other Non Cash Items Correlation Analysis

Correlation Coefficient

Free Cash Flow

Other Non Cash Items

Vaxcyte fundamental ratios Correlations

Vaxcyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vaxcyte fundamental ratios Accounts

Also Currently Popular

Additional Tools for Vaxcyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Currrent Assets Other	+ 1.0	Other Current Liab
Total Current Assets	+ 1.0	Total Stockholder Equity
Long Term Debt Total	+ 1.0	Long Term Debt

Net Debt	- 0.99	Cash
Total Current Assets	- 0.98	Retained Earnings
Common Stock	- 0.98	Other Liab
Net Tangible Assets	- 0.98	Other Liab
Retained Earnings	- 0.98	Total Assets
Common Stock	- 0.97	Retained Earnings